Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
49 studies found for:    Open Studies | "Growth Disorders"
Show Display Options
Rank Status Study
21 Recruiting Obesity and Oral Contraceptive Failure
Conditions: Contraception;   Fetal Growth Retardation;   Infant, Small for Gestational Age;   Obesity
Intervention:
22 Unknown  Genetic Study of Insulin-Like Growth Factor-I Receptor Mutations in Patients With Intrauterine Growth Retardation
Condition: Intrauterine Growth Retardation
Intervention:
23 Not yet recruiting Evaluation of Fetoplacental Oxygenation With Functional MRI in Pregnant Women
Condition: Intrauterine Growth Restriction
Interventions: Other: Bold sequence patients test;   Other: Bold sequence
24 Recruiting EG-VEGF : Potential Marker of Pre-eclampsia and / or Intrauterine Growth Restriction
Conditions: Pre-eclampsia;   Intra-uterine Growth Retardation
Intervention: Other: blood sample and doppler Ultrasound of uterine arteries
25 Recruiting EVERREST Developing a Therapy for Fetal Growth Restriction
Condition: Fetal Growth Retardation
Intervention:
26 Recruiting A Cluster-Randomized Trial of Ultrasound Use to Improve Pregnancy Outcomes in Low Income Country Settings
Conditions: Pregnancy;   Eclampsia;   Placenta Previa;   Stillbirth;   Fetal Growth Restriction
Intervention: Device: Antenatal Ultrasound Scan
27 Recruiting Consequences of Antiangiogenic Factors Involved in Preeclampsia on Intra-uterine Growth Restricted Preterm Newborn
Conditions: Preterm Birth;   Intra-uterine Growth Restriction;   Maternal Preeclampsia;   Bronchopulmonary Dysplasia
Intervention: Other: Biological samples
28 Not yet recruiting Diffusion-weighted Cerebral MRI and Intra Uterine Growth Restriction.
Condition: Pregnant Women With Foetuses Presenting With Intra-uterine Growth Restriction
Intervention: Radiation: Pregnant women with intra-uterine growth restricted Foetuses
29 Unknown  Sildenafil and Uteroplacental Perfusion
Condition: Fetal Growth Retardation
Interventions: Drug: sildenafil;   Drug: placebo
30 Unknown  Study to Examine Insulin Resistance During Growth Hormone Treatment for Short Stature Due to Low Birthweight
Condition: Fetal Growth Retardation
Intervention: Drug: somatropin (rDNA)
31 Recruiting MRI Assessment of Placental Health
Condition: Intrauterine Growth Restriction
Intervention: Other: Oxygen
32 Recruiting Prediction of Growth Restricted Fetuses Using Femur Length to Mid-thigh Circumference Ratio: A Case-control Study
Condition: Fetal Growth Restriction
Intervention:
33 Not yet recruiting A Randomized Trial of Docosahexaenoic Acid Supplementation During Pregnancy to Prevent Deep Placentation Disorders
Conditions: Premature Birth;   Preeclampsia;   Fetal Growth Retardation;   Stillbirth
Interventions: Dietary Supplement: Docosahexaenoic acid (DHA);   Dietary Supplement: Placebo (for Docosahexaenoic acid (DHA))
34 Recruiting First-trimester Prediction of Preeclampsia
Conditions: Preeclampsia;   Severe Preeclampsia;   Fetal Growth Restriction;   Preterm Birth
Intervention:
35 Unknown  Preterm Fetal Growth Restriction and Developmental Care
Condition: Preterm Birth
Intervention: Behavioral: NIDCAP (Newborn Individualized Developmental Care)
36 Unknown  A Modernized Approach to Prenatal Care in Low Risk Women
Conditions: Pre-eclampsia;   Intrauterine Growth Retardation
Intervention: Other: Modernized prenatal care
37 Unknown  Progesterone for First Trimester Vaginal Bleeding
Conditions: Threatened Abortion;   Pre-Eclampsia;   Abruptio Placentae;   Fetal Growth Retardation;   Premature Birth
Interventions: Drug: dihydroxyprogesterone caproate;   Drug: Placebo
38 Unknown  Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome
Conditions: Fetal Demise;   Fetal Growth Restriction;   Preeclampsia;   Abruptio Placentae;   Thromboembolism
Intervention: Drug: enoxaparin
39 Not yet recruiting The Dutch STRIDER (Sildenafil TheRapy In Dismal Prognosis Early-onset Fetal Growth Restriction)
Condition: Fetal Growth Restriction
Interventions: Drug: Sildenafil;   Drug: Placebo
40 Unknown  The Role of Pro-angiogenic Immune Cells in Human Pregnancies
Conditions: Fetal Growth Retardation;   Preeclampsia
Intervention: Other: Biological specimen

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-49) Show next page of results    Last Page
Indicates status has not been verified in more than two years